• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSISST) BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSISST) BYPASS Back to Search Results
Model Number 106524US
Device Problems Mechanical Problem (1384); Obstruction of Flow (2423)
Patient Problems Obstruction/Occlusion (2422); Thrombosis/Thrombus (4440)
Event Date 08/09/2021
Event Type  Injury  
Manufacturer Narrative
No further information was provided.A supplemental report will be submitted once the manufacturer¿s investigation is completed.
 
Event Description
It was reported that the patient had an outflow graft obstruction that required frequent monitoring of the patient's condition.The obstruction was confirmed via computed tomography angiography (cta).The outflow graft showed a significant amount of thrombosis proximally.The shape of the thrombus both cysts in somewhat amorphic; however, overall luminal narrowing was approximately (b)(6) at its maximum.Thrombus was seen in the proximal 8 cm of the graft.
 
Manufacturer Narrative
Section d9: correction; the pump was returned under manufacturer report number 2916596-2021-06606.Manufacturer's investigation conclusion: the report of outflow graft thrombosis could not be confirmed through this evaluation as no photos or images were submitted.The pump was returned under manufacturer report number 2916596-2021-06606; refer to this investigation for pump evaluation.It was reported that the outflow graft showed a significant amount of thrombosis in the proximal 8 centimeters of the graft.The shape of the thrombus was noted as cystic and somewhat amorphic.Overall luminal narrowing of the thrombus was approximately 65-70% at its maximum.The patient remained ongoing on heartmate 3 left ventricular assist system (lvas), serial number (b)(6), until undergoing heart transplantation on (b)(6) 2021 due to outflow graft occlusion (manufacturer report number 2916596-2021-06606).The heartmate 3 left ventricular assist system (lvas) instruction for use (ifu), rev.C, is currently available.Section 1 of this document entitled ¿introduction¿ lists pump thrombosis as an adverse event that may be associated with the use of the heartmate 3 lvas.Section 5 of the ifu, "surgical procedures", contains information on "preparing the sealed outflow graft" and explains that prior to implantation, the bend relief should be disengaged from the graft for the de-airing procedure.Section 5 also contains a sub-section on "attaching the sealed outflow graft to the aorta", which instructs the user to stretch the graft completely and then measure and cut the sealed outflow graft to the appropriate length.Section 5, under "attaching the sealed outflow graft to the pump", instructs the user to verify that the outflow graft is not twisted or kinked by checking the position of the black line on the graft above and below the bend relief and ensuring that the line is straight.Section 5, under "de-airing the pump", cautions the user: "do not rotate/twist the sealed graft.Check the alignment of the black line on the graft to verify that the sealed graft is not twisted or kinked." this section also explains how to attach the bend relief once the vent needle has been removed from the sealed outflow graft and leaks have been ruled out.Section 1 lists the outflow graft clip as a required component for implant.Section 5, further instructs the user to ¿attach the outflow graft clip to prevent post-operative outflow graft twisting¿ and warns that failure to install the outflow graft clip so that it is flush with the bend relief can allow graft twisting or abrasion which may lead to serious adverse events such as bleeding, graft occlusion, thrombosis, and/or death.Section 6 entitled ¿patient care and management¿ lists thromboembolism as a potential late postimplant complication and provides information regarding anticoagulation, including recommended international normalized ratio (inr) values.The relevant sections of the device history records for (b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specification.No further information was provided.The manufacturer is closing the file on this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTMATE 3 LVAS IMPLANT KIT
Type of Device
VENTRICULAR (ASSISST) BYPASS
Manufacturer (Section D)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer (Section G)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer Contact
bob fryc
6035 stoneridge drive
pleasanton, CA 94588
7818528204
MDR Report Key12924479
MDR Text Key284697110
Report Number2916596-2021-06791
Device Sequence Number1
Product Code DSQ
UDI-Device Identifier00813024013297
UDI-Public00813024013297
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P160054
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/08/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date04/11/2022
Device Model Number106524US
Device Catalogue Number106524US
Device Lot Number7034374
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/01/2021
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 11/04/2021
Initial Date FDA Received12/03/2021
Supplement Dates Manufacturer Received02/07/2022
Supplement Dates FDA Received02/08/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/07/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age30 YR
Patient SexFemale
Patient Weight99 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-